Clinical effect of tacrolimus in the treatment of myasthenia gravis in children

To evaluate the efficacy and safety of tacrolimus in the treatment of children with myasthenia gravis (MG). A total of 28 children with MG were treated with tacrolimus. MG-Activities of Daily Living (MG-ADL) scale was used to assess clinical outcome and safety after 1, 3, 6, 9, and 12 months of trea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Zhongguo dang dai er ke za zhi 2020-09, Vol.22 (9), p.964
Hauptverfasser:	Li, Jiu-Wei, Fang, Fang, Ren, Xiao-Tun, Zhang, Wei-Hua, Yang, Xin-Ying, Ren, Chang-Hong, Gong, Shuai, Lyu, Jun-Lan, Wang, Xiao-Hui, Wang, Xu, Wu, Hu-Sheng, Ding, Chang-Hong
Format:	Artikel
Sprache:	chi
Schlagworte:	Activities of Daily Living Child Humans Immunosuppressive Agents Myasthenia Gravis - drug therapy Neoplasm Recurrence, Local Tacrolimus - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To evaluate the efficacy and safety of tacrolimus in the treatment of children with myasthenia gravis (MG). A total of 28 children with MG were treated with tacrolimus. MG-Activities of Daily Living (MG-ADL) scale was used to assess clinical outcome and safety after 1, 3, 6, 9, and 12 months of treatment. After tacrolimus treatment, the MG-ADL score at 1, 3, 6, 9 and 12 months was lower than that at baseline (P
ISSN:	1008-8830